Alzheimer's Disease Trial, Not Yet Recruiting NCT07031167 Sponsor: Fundació ACE Institut Català de Neurociències Aplicades Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07031167
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 60 and 85 years.
  • People who have been diagnosed with Mild Cognitive Impairment (MCI) — a condition involving mild memory or thinking changes — based on specific medical criteria, with a rating of 0.5 on a standard memory assessment scale called the CDR.
  • People who have been diagnosed with mild Alzheimer's disease dementia according to recognised international guidelines, with a CDR score of 1.
  • People who are comfortable using digital tools such as mobile apps, tablets, or computers.
  • People who are able and willing to attend regular in-person visits at Ace Alzheimer Center Barcelona.
  • People who have given written consent to participate after being fully informed about the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a history of traumatic brain injury.
  • People who have been diagnosed with severe depression.
  • People who have a history of stroke or brain tumours.
  • People who have significant vision or hearing difficulties that have not been corrected.
  • People who do not have access to a digital device or internet connection.
  • People who are unable to attend regular in-person sessions at the study site.
  • People who have a medical condition that could interfere with memory and thinking assessments or limit their ability to take part (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 934447318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Fundació ACE Institut Català de Neurociències Aplicades
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
1 July 2028

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Changes in neuropsychological assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov